Impact Factor
3.34
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.80
515 total citations
h5-index
36
h5 depth signal
Cited share
60.7%
122 of 201
Total citations
515
Citation footprint
Metric signal
3.03
External metric anchor
Self-citation
2.7%
14 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
507
United States
140
India
138
Iran
100
Italy
64
Citing Fields of Research
Cell Biology
242
Noncoding RNA
234
Genetics & Genomics
204
Cancer, Autophagy & Apoptosis
178
Cancer & Development
127
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,085
Articles tracked across the journal lifetime
Indexed publication set
201
122 cited publications
Last 12 months
70
5.8 publications/month
Open access share
21.4%
15 OA publications in the last year
Leading citing country
China
507 citing publications
Leading citing field
Cell Biology
242 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v48n1, July 1999-
v48n1, July 1999-
Active Coverage
Research Focus & Classification
Indexed Subjects
Noncoding RNA
Cancer, Autophagy & Apoptosis
Cancer & Development
Breast Cancer
Immunology
Genetics & Genomics
Issuing & Sponsoring Bodies
Contributor
International Union of Biochemistry and Molecular Biology
Broad Categories
Biochemistry
Molecular Biology
Cancer, Autophagy & Apoptosis
Nucleic Acids Chemistry
Noncoding RNA
Mitochondria
Cancer & Development
Cancer Drugs
MeSH Descriptors
Biochemistry
Molecular Biology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/iub.70136
Open DOI
Icariin Protects Against Mitochondrial Damage and Ferroptosis‐Related Injury in Synovial Fibroblast‐Like Synoviocytes Through SUMO1 ‐Dependent Regulation of SIRT1
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation and progressive joint destruction, in which fibroblast‐like synoviocytes (FLSs) play a central pathogenic role. Ferroptosis and o...
02
DOI 10.1002/iub.70137
Open DOI
The Receptor for Advanced Glycation End Products: Regulation and Implications in Metabolic Diseases
Receptor for advanced glycation end‐products (RAGE) was originally identified as a receptor for advanced glycation end‐products; however, it can also bind a broader range of damage‐associated molecular patterns, including S100 proteins, ...
03
DOI 10.1002/iub.70138
Open DOI
Spatial Transcriptomic and CITE ‐Seq Analyses Identify Clearance‐Defective Signatures in Psoriatic Disease
Psoriatic lesions contain sustained inflammatory stress, but whether death‐associated tissue activity is matched by adequate clearance capacity remains poorly defined. To address this, spatial transcriptomics was used to define clearance...
04
05
DOI 10.1002/iub.70124
Open DOI
Causal Associations Between Plasma Metabolites and Stroke Risk Identified by Mendelian Randomization
Stroke is a leading cause of global mortality and morbidity, yet its underlying metabolic mechanisms remain largely undefined. Elucidating the causal role of blood metabolites in stroke pathogenesis is crucial for developing effective in...
06
DOI 10.1002/iub.70135
Open DOI
Predicting Hormesis Effects of GenX in Zebrafish via Interpretable Machine Learning: Insights From SHAP Analysis
Hexafluoropropylene oxide‐dimer acid (GenX), a prominent alternative to legacy per‐ and polyfluoroalkyl substances (PFAS), poses a significant challenge to traditional linear risk assessment models due to its ability to induce hormesis—a...
07
DOI 10.1002/iub.70114
Open DOI
Issue Information
08
DOI 10.1002/iub.70131
Open DOI
Oncostatin M as a Multifunctional Regulator of Breast Cancer Progression: Current Insights and Future Therapeutic Avenues
Breast cancer (BC) constitutes the most prevalent malignancy globally, with an incidence of approximately 80%–85% for invasive ductal carcinoma (IDC) and 10%–15% for invasive lobular carcinoma (ILC), and a persistently high mortality and...
09
DOI 10.1002/iub.70130
Open DOI
MMP9 Knockout by CRISPR ‐Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti‐ PD ‐ L1 in an Orthotopic Mouse Model
Bladder cancer (BC) is the 10th most common cancer worldwide, accounting for approximately 5% of new cases. Several factors contribute to tumor progression, including increased MMP9. Recently, CRISPR‐Cas9 and immunotherapy have offered h...
10
DOI 10.1002/iub.70126
Open DOI
N ‐Acetyl Cysteine Mitigates d ‐Ribose‐Induced Protein Glycation and Aggregation Through Multiple Protective Mechanisms
Advanced glycation end‐products (AGEs) arise from non‐enzymatic reactions between reducing sugars and proteins, contributing to oxidative stress and metabolic dysfunction. Excessive AGE accumulation is implicated in chronic diabetic comp...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 66 (2014).
Also issued online.